Cancer Res Treat.  2021 Apr;53(2):323-329. 10.4143/crt.2020.1256.

Guidelines for Cancer Care during the COVID-19 Pandemic in South Korea

• Lee JB
• Jung M
• Kim JH
• Kim BH
• Kim Y
• Kim YS
• Kim BC
• Kim J
• Moon SH
• Park KU
• Park M
• Park HJ
• Sim SH
• Yoon HM
• Lee SJ
• Lee E
• Chun JY
• Chung YK
• Jung SY
• Chung J
• Lee ES
• Chung HC
• Yun T
• Rha SY

• KMID: 2514915
• DOI: http://doi.org/10.4143/crt.2020.1256

Abstract

At the end of 2019, the cause of pneumonia outbreaks in Wuhan, China, was identified as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. In February 2020, the World Health Organization named the disease cause by SARS-CoV-2 as coronavirus disease 2019 (COVID-19). In response to the pandemic, the Korean Cancer Association formed the COVID-19 task force to develop practice guidelines. This special article introduces the clinical practice guidelines for cancer patients which will help oncologists best manage cancer patients during the COVID-19 pandemic.

Keyword

Cancer care; COVID-19; Guideline; Korea

Figure

• 

  Fig. 1 Basic algorithm for screening, treatment and follow-up during coronavirus disease 2019 (COVID-19). a)Indications for COVID-19 screening includes one of the following: (1) symptoms related to COVID-19, (2) history of recent overseas travel within 14 days, contact with a COVID-19 patient, b)Delay: Refer to Table 2 for summary of recommendations for cancer screening.

Reference

References

1. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020; 382:727–33.

2. Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020; 395:565–74.

3. Dighe A, Cattarino L, Cuomo-Dannenburg G, Skarp J, Imai N, Bhatia S, et al. Response to COVID-19 in South Korea and implications for lifting stringent interventions. BMC Med. 2020; 18:321.

4. Jazieh AR, Akbulut H, Curigliano G, Rogado A, Alsharm AA, Razis ED, et al. Impact of the COVID-19 pandemic on cancer care: a global collaborative study. JCO Glob Oncol. 2020; 6:1428–38.

5. Lambertini M, Toss A, Passaro A, Criscitiello C, Cremolini C, Cardone C, et al. Cancer care during the spread of coronavirus disease 2019 (COVID-19) in Italy: young oncologists’ perspective. ESMO Open. 2020; 5:e000759.

6. de Joode K, Dumoulin DW, Engelen V, Bloemendal HJ, Verheij M, van Laarhoven HW, et al. Impact of the coronavirus disease 2019 pandemic on cancer treatment: the patients’ perspective. Eur J Cancer. 2020; 136:132–9.

7. Neal RD, Nekhlyudov L, Wheatstone P, Koczwara B. Cancer care during and after the pandemic. BMJ. 2020; 370:m2622.

8. Burki TK. Cancer guidelines during the COVID-19 pandemic. Lancet Oncol. 2020; 21:629–30.

9. Ueda M, Martins R, Hendrie PC, McDonnell T, Crews JR, Wong TL, et al. Managing cancer care during the COVID-19 pandemic: agility and collaboration toward a common goal. J Natl Compr Canc Netw. 2020; 18:366–9.

10. Rhee SW. Management of used personal protective equipment and wastes related to COVID-19 in South Korea. Waste Manag Res. 2020; 38:820–4.

11. Saab R, Obeid A, Gachi F, Boudiaf H, Sargsyan L, Al-Saad K, et al. Impact of the coronavirus disease 2019 (COVID-19) pandemic on pediatric oncology care in the Middle East, North Africa, and West Asia region: a report from the Pediatric Oncology East and Mediterranean (POEM) group. Cancer. 2020; 126:4235–45.

12. Ljungman P, Mikulska M, de la Camara R, Basak GW, Chabannon C, Corbacioglu S, et al. The challenge of COVID-19 and hematopoietic cell transplantation; EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapy. Bone Marrow Transplant. 2020; 55:2071–6.

13. Son BK, Kim BW, Kim WH, Myung DS, Cho YS, Jang BI, et al. Korean Society of Gastrointestinal Endoscopy guidelines for endoscope reprocessing. Clin Endosc. 2017; 50:143–7.